Ligelizumab for Chronic Spontaneous Urticaria-Reference-Cited by-同舟云学术

Ligelizumab for Chronic Spontaneous Urticaria

Published:2019-10-03 Issue:14 Volume:381 Page:1321-1332
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Maurer Marcus¹,Giménez-Arnau Ana M.¹,Sussman Gordon¹,Metz Martin¹,Baker Diane R.¹,Bauer Andrea¹,Bernstein Jonathan A.¹,Brehler Randolf¹,Chu Chia-Yu¹,Chung Wen-Hung¹,Danilycheva Inna¹,Grattan Clive¹,Hébert Jacques¹,Katelaris Constance¹,Makris Michael¹,Meshkova Raisa¹,Savic Sinisa¹^ORCID,Sinclair Rodney¹,Sitz Karl¹,Staubach Petra¹,Wedi Bettina¹,Löffler Jürgen¹,Barve Avantika¹,Kobayashi Kenneth¹,Hua Eva¹,Severin Thomas¹,Janocha Reinhold¹

Affiliation:

1. From the Department of Dermatology and Allergy, Charité–Universitätsmedizin Berlin, Berlin (M. Maurer, M. Metz), the Department of Dermatology, University Allergy Center, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden (A. Bauer), the Department of Dermatology, University Hospital Münster, Münster (R.B.), the Department of Dermatology, University Medical Center Mainz, Mainz (P.S.), and the Department of Dermatology and Allergy, Comprehensive Allergy Center, Hannover Medical...

Funder

Novartis Pharma

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1900408

Cited by 211 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Placebo on Pruritus in Patients with Chronic Urticaria: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials;Clinical Drug Investigation;2024-09-06

2. Therapeutic monoclonal antibodies in allergy: Targeting IgE, cytokine, and alarmin pathways;Immunological Reviews;2024-08-19

3. The potential of Bruton’s tyrosine kinase (BTK) inhibitors in the pharmacotherapeutic management of immune and dermatological disease;Expert Opinion on Pharmacotherapy;2024-08-12

4. Urticaria Management in North America: What We Know and What We Do Not Know;Current Treatment Options in Allergy;2024-08-06

5. Mast cell stabilizers: from pathogenic roles to targeting therapies;Frontiers in Immunology;2024-08-01